- Home
- FKWL vs PRLD Comparison
FKWL vs PRLD Comparison
Compare FKWL & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FKWL
- PRLD
- Stock Information
- Founded
- FKWL 1981
- PRLD 2016
- Country
- FKWL United States
- PRLD United States
- Employees
- FKWL N/A
- PRLD N/A
- Industry
- FKWL Telecommunications Equipment
- PRLD Medicinal Chemicals and Botanical Products
- Sector
- FKWL Utilities
- PRLD Health Care
- Exchange
- FKWL Nasdaq
- PRLD Nasdaq
- Market Cap
- FKWL 71.6M
- PRLD 73.7M
- IPO Year
- FKWL 1996
- PRLD 2020
- Fundamental
- Price
- FKWL $5.61
- PRLD $0.82
- Analyst Decision
- FKWL
- PRLD Strong Buy
- Analyst Count
- FKWL 0
- PRLD 2
- Target Price
- FKWL N/A
- PRLD $4.50
- AVG Volume (30 Days)
- FKWL 38.6K
- PRLD 201.7K
- Earning Date
- FKWL 05-14-2025
- PRLD 03-10-2025
- Dividend Yield
- FKWL N/A
- PRLD N/A
- EPS Growth
- FKWL N/A
- PRLD N/A
- EPS
- FKWL N/A
- PRLD N/A
- Revenue
- FKWL $43,443,375.00
- PRLD $7,000,000.00
- Revenue This Year
- FKWL N/A
- PRLD N/A
- Revenue Next Year
- FKWL N/A
- PRLD N/A
- P/E Ratio
- FKWL N/A
- PRLD N/A
- Revenue Growth
- FKWL N/A
- PRLD N/A
- 52 Week Low
- FKWL $2.90
- PRLD $0.63
- 52 Week High
- FKWL $7.45
- PRLD $6.80
- Technical
- Relative Strength Index (RSI)
- FKWL 42.29
- PRLD 56.29
- Support Level
- FKWL $5.12
- PRLD $0.71
- Resistance Level
- FKWL $6.23
- PRLD $0.76
- Average True Range (ATR)
- FKWL 0.42
- PRLD 0.07
- MACD
- FKWL -0.06
- PRLD 0.02
- Stochastic Oscillator
- FKWL 41.10
- PRLD 87.50
About FKWL Franklin Wireless Corp.
Franklin Wireless Corp is a provider of wireless solutions, including mobile hotspots, routers, and modems, as well as hardware and software products that support machine-to-machine (M2M) applications and the Internet of Things (IoT). Its M2M and IoT solutions include embedded modules, modems, and gateways built to deliver reliable always-on connectivity supporting a spectrum of applications. These products are designed to solve wireless connectivity challenges in a range of vertical markets, including video surveillance, digital signage, home security, oil and gas exploration, kiosks, fleet management, smart grid, vehicle diagnostics, and telematics.
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.